Respiratory Research · 2019 · 43 citations · 30 references
Public HealthInfectious Disease ControlInfectious DiseasesAntimicrobial ResistanceInfectious Disease EpidemiologyTuberculosis ControlAntibiotic ResistancePulmonary TuberculosisResistance EpidemiologyTuberculosis CareTuberculosis EpidemiologyTuberculosis PreventionAntimicrobial Resistance PatternsChi-square TestDrug Resistance PatternsEconomic Burden Of DiseaseEconomic Burden Of IllnessJoinpoint Trend AnalysisPhenotypic Drug Susceptibility TestingTuberculosis Drug Resistance
BACKGROUND: Primary drug-resistant tuberculosis (DR-TB) has contributed to a significant health and economic burden on a global scale, especially in China. we sought to estimate epidemiological characteristics of primary DR-TB in China from 2004 to 2018. METHODS: Eleven thousand four hundred sixty-seven newly diagnosed and 1981 retreated TB cases with drug susceptibility data were included. Chi-Square test for trends, linear regression, a joinpoint regression model and temporal trend in proportions of the different resistance patterns were carried out. RESULTS: The proportion of primary DR-TB and mono-resistant TB (MR-TB) in China had reduced by more than 12% since 2004, and were 21.38%, 13.35% in 2018 respectively. Among primary DR-TB cases (2173,18.95%), the percentage of multiresistant TB (MDR-TB, from 5.41 to 17.46%), male (from 77.03 to 84.13%), cavity (from 13.51 to 43.92%), rifampicin(RFP)-resistant TB (from 8.11 to 26.98%), streptomycin(SM)-resistant TB (from 50.00 to 71.43%) increased significantly (P < 0.05). On the contrary, the proportion of female, non-cavity, isoniazide(INH)-resistant TB (from 55.41 to 48.15%) and MR-TB (from 82.43 to 62.43%) decreased significant (P < 0.05). The primary drug resistance rate among female, cavity, smoking, drinking, 15 to 44 year-old TB subgroups increased by 0.16, 6.24, 20.95, 158.85, 31.49%, respectively. The percentage of primary DR-TB, RFP-resistant TB dropped significantly during 2004-2007 in Joinpoint regression model. CONCLUSION: The total rate of drug resistance among new TB cases showed a downward trend in Shandong, China, from 2004 to 2018. Primary drug resistance patterns were shifting from female, non-cavity, INH-resistant TB, and MR-TB groups to male, cavity, RFP/SM-resistant TB, and MDR-TB groups. Considering the rising drug resistance rate among some special population, future control of primary DR-TB in China may require an increased focus on female, cavity, smoking, drinking, or 15 to 44 year-old TB subgroups.
30
Global tuberculosis report (2014)
L.A. Gabbasova, E.R. Experts Who · 2014 · 13.2K citations
National Survey of Drug-Resistant Tuberculosis in China
Yanlin Zhao, Shaofa Xu, Lixia Wang et al. · New England Journal of Medicine · 2012 · 645 citations · Full text
Tuberculosis prevalence in China, 1990–2010; a longitudinal analysis of national survey data
Lixia Wang, Hui Zhang, Yunzhou Ruan et al. · The Lancet · 2014 · 562 citations